Rates of at least 14 cancer types are increasing in people under age 50, and researchers still don’t have a definitive explanation. A comprehensive NCI-led study published in May 2025 confirmed the trend extends well beyond colorectal cancer—breast, uterine, kidney, and more than 10 other common cancers are all climbing among younger populations. The sharpest increases are hitting the 20–29 age range, and early-onset colorectal cancer is now becoming a leading cause of cancer deaths among young adults in the United States.

Why It Matters

Cancer has long been considered a disease of aging. The average age at colorectal cancer diagnosis was 72 as recently as 2009; today it’s 67, according to Y. Nancy You, M.D., who directs the Young-Onset Colorectal Cancer Program at the University of Texas MD Anderson Cancer Center. That five-year shift in median diagnosis age represents millions of people encountering a life-altering disease during their most productive decades—while raising children, building careers, and assuming they’re too young for cancer.

The trend gained widespread public attention in 2020 when actor Chadwick Boseman died of colorectal cancer at 43. But the data show this is not a collection of anecdotes. A study by American Cancer Society researchers found that early-onset colorectal cancer rates have increased in 27 of 50 countries analyzed. Globally, nearly 10% of all new colorectal cancer diagnoses now occur in people under 50. And critically, death rates from colorectal, uterine, and testicular cancers are also rising in that age group.

What Researchers Are Finding

No single cause has emerged, and experts believe one won’t. Multiple studies point to overlapping contributors: obesity, heavy alcohol consumption, environmental exposures (including microplastics), and disruptions to the gut microbiome. One recent study implicated a DNA-damaging toxin produced by certain strains of E. coli as a potential driver of colorectal cancer specifically.

“I don’t think there’s going to be a single ‘smoking gun.’ It’s the million-dollar question everybody [is asking]. But it’s a long-horizon answer.”
— Y. Nancy You, M.D., University of Texas MD Anderson Cancer Center

Some researchers describe a birth cohort effect: people born from the 1950s onward have been exposed to shifting environmental, dietary, and lifestyle factors that may accelerate the timeline for cancer development. Dr. You frames it as a “whole package” of common factors creating a new biological window for cancer in younger populations.

Ulrike Peters, Ph.D., of the Fred Hutch Cancer Center, cautioned at the April 2025 AACR meeting that “for many of these [factors], there’s no strong epidemiological evidence that they’re [individually] linked to early-onset cancers.” The interplay between factors—not any one variable—appears to be what matters.

Genetically, early-onset cancers don’t neatly separate from later-onset disease. In people under 35 treated at Memorial Sloan Kettering, nearly 20% had a germline (inherited) genetic predisposition to cancer, often involving BRCA1, BRCA2, or Lynch syndrome genes. But Zsofia Stadler, Ph.D., of MSKCC stressed that germline mutations explain only a modest share of cases overall. As Dr. Peters put it: “Genetics cannot explain the rise we have seen in early-onset cancers. Our genome just doesn’t change so quickly over several decades.”

The Numbers

• 14 cancer types showed increased rates in at least one age group under 50 between 2010 and 2019 (NCI-led study, May 2025)
• 9 of those same cancers also increased in people over 50 in at least one 10-year age group
• Nearly 10% of new colorectal cancers globally occur in people under 50
• 27 of 50 countries showed rising early-onset colorectal cancer rates (ACS study)
• ~20% of early-onset cancer patients under 35 at MSKCC had inherited cancer-related genetic changes
• 20–30% of early-onset colorectal cancers involve Lynch syndrome, which responds well to immunotherapy
• Average U.S. colorectal cancer diagnosis age dropped from 72 (2009) to 67 (current)
• Symptom-to-diagnosis delay for early-onset colorectal cancer is often 6 months or longer

Yin Cao, M.Sc., of Washington University Siteman Cancer Center, is leading PROSPECT, the first research program of its kind dedicated to investigating causes of early-onset colorectal cancer. Funded by NCI, Cancer Research UK, Bowelbabe Fund, and Institut National du Cancer through the Cancer Grand Challenges program, PROSPECT is international in scope—because the problem is international.

What Comes Next

The PROSPECT program represents one of the most ambitious efforts to date. Its international scope reflects the reality that early-onset cancers are rising across high-income and middle-income countries alike, not just in the U.S. Researchers are also pushing for better integration of data across all age groups. Meredith Shiels, Ph.D., of NCI’s Division of Cancer Epidemiology and Genetics, emphasized that “we can learn something … by looking across all age groups,” since nine of the 14 rising cancer types affect older populations too.

On the clinical side, genetic testing at the point of diagnosis is becoming standard, particularly for Lynch syndrome. Dr. You stressed its importance: tumors in people with Lynch syndrome “respond phenomenally well to immunotherapy,” making identification of these patients a clinical priority. Awareness campaigns are also shifting clinician behavior—Andrea Dwyer, M.P.H., of the University of Colorado Cancer Center, noted that many providers have stopped ruling out cancer based on a patient’s age alone.

The harder shift is behavioral. Younger adults tend to dismiss symptoms. A 2023 study led by Dr. Cao identified rectal bleeding, abdominal pain, diarrhea, and iron deficiency anemia as key warning signs of early-onset colorectal cancer. The gap between first symptoms and diagnosis is frequently half a year or longer—a delay that can mean the difference between localized and advanced disease.

What This Means for You

You cannot control your birth cohort. But the factors researchers keep circling—gut microbiome disruption, chronic inflammation, obesity, alcohol, metabolic dysfunction—are categories where lifestyle choices carry real weight. That’s not a guarantee of prevention, but it is leverage, and the science supports pulling those levers consistently.

Support your gut microbiome. The research increasingly points to gut dysbiosis as a potential contributor to early-onset cancers. A diet rich in polyphenols, fiber, and diverse plant compounds provides the raw material your microbiome needs. A quality greens supplement can help fill gaps in micronutrient and polyphenol intake, particularly on days when your whole-food game falls short.

Prioritize metabolic health. Obesity and insulin resistance show up repeatedly in the early-onset cancer literature. Adequate protein intake supports blood sugar stability, satiety, and lean mass retention—three pillars of long-term metabolic health that also happen to support cancer risk reduction.

Don’t ignore recovery and inflammation. Chronic low-grade inflammation is a through-line in nearly every cancer-risk discussion. Sleep quality, stress management, and intentional recovery protocols are not luxuries—they’re part of a risk-reduction framework. If you train hard, build recovery into your program with the same discipline you bring to the gym.

Close your micronutrient gaps. Vitamin D status, B-vitamin sufficiency, and mineral balance all intersect with immune function and cellular repair. A targeted vitamin regimen built around your actual gaps—ideally confirmed by bloodwork with your physician—is a practical step that costs little and compounds over time.

None of this replaces screening or medical care. If you’re under 50 and experiencing persistent GI symptoms—rectal bleeding, unexplained abdominal pain, changes in bowel habits, or iron deficiency anemia—see your doctor. Don’t wait six months hoping it resolves on its own.

The Bigger Picture

The rise in early-onset cancers is not a single-cause crisis, and it won’t have a single-cause solution. What the research makes clear is that the environment younger generations grew up in—dietary shifts, microbiome disruption, environmental exposures—has changed the biological timeline for diseases once considered problems of old age. The science hasn’t caught up to fully explain why, but it has caught up enough to tell us where to focus: gut health, metabolic fitness, inflammation management, and vigilance about symptoms. Those aren’t cures. They’re the best tools available right now, and they’re worth using.

Sources

• As Rates of Some Cancers Increase in Younger People, Researchers Search for Answers — National Cancer Institute, Cancer Currents Blog, May 14, 2025
• Background statistics: American Cancer Society (global early-onset colorectal cancer rates)
• Background statistics: National Cancer Institute, Division of Cancer Epidemiology and Genetics (14-cancer-type analysis, 2010–2019)
• PROSPECT program: Cancer Grand Challenges, funded by NCI, Cancer Research UK, Bowelbabe Fund, Institut National du Cancer